UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.017

Sortiert nach

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

Nature immunology, 2010-02, Vol.11 (2), p.155

2010

Link zum Volltext

Verfügbarkeit prüfen

Phosphorylation of the BNIP3 C-Terminus Inhibits Mitochondrial Damage and Cell Death without Blocking Autophagy

PloS one, 2015-06, Vol.10 (6), p.e0129667-e0129667

2015

Link zum Volltext

Verfügbarkeit prüfen

Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma

Cancer letters, 2015-05, Vol.360 (2), p.302-309

2015

Link zum Volltext

Verfügbarkeit prüfen

Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis

Nature, 2009-01, Vol.457 (7227), p.318-321

2009

Link zum Volltext

Verfügbarkeit prüfen

CD47 Is Necessary for Inhibition of Nitric Oxide-stimulated Vascular Cell Responses by Thrombospondin-1

The Journal of biological chemistry, 2006-09, Vol.281 (36), p.26069-26080

2006

Link zum Volltext

Verfügbarkeit prüfen

Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling

Blood, 2008-01, Vol.111 (2), p.613-623

2008

Link zum Volltext

Verfügbarkeit prüfen

Differential Interactions of Thrombospondin-1, -2, and -4 with CD47 and Effects on cGMP Signaling and Ischemic Injury Responses

The Journal of biological chemistry, 2009-01, Vol.284 (2), p.1116-1125

2009

Link zum Volltext

Verfügbarkeit prüfen

Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia

Blood, 2005-05, Vol.105 (9), p.3577-3582

2005

Link zum Volltext

Verfügbarkeit prüfen

CD47 blockade triggers T cell-mediated destruction of immunogenic tumors

Nature medicine, 2015-10, Vol.21 (10), p.1209-1215

2015

Link zum Volltext

Verfügbarkeit prüfen

Inhibitory signaling through signal regulatory protein-α is not sufficient to explain the antitumor activities of CD47 antibodies

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (42), p.E2842-E2842; author reply E2845

2012

Link zum Volltext

Verfügbarkeit prüfen

CD47 mediates killing of breast tumor cells via Gi-dependent inhibition of protein kinase A

Cancer research (Chicago, Ill.), 2004-02, Vol.64 (3), p.1026-1036

2004

Link zum Volltext

Verfügbarkeit prüfen

Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress

Matrix biology, 2009-03, Vol.28 (2), p.110-119

2009

Link zum Volltext

Verfügbarkeit prüfen

CD47 Regulates Bone Mass and Tumor Metastasis to Bone

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (7), p.3196-3204

2009

Link zum Volltext

Verfügbarkeit prüfen

Treatment of liver ischemia–reperfusion injury by limiting thrombospondin-1/CD47 signaling

Surgery, 2008-11, Vol.144 (5), p.752-761

2008

Link zum Volltext

Verfügbarkeit prüfen

Imaging of CD47 Expression in Xenograft and Allograft Tumor Models

Molecular imaging, 2013-11, Vol.12 (8), p.7290

2013

Link zum Volltext

Verfügbarkeit prüfen

Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding

Molecular cancer therapeutics, 2020-03, Vol.19 (3), p.835-846

2020

Link zum Volltext

Verfügbarkeit prüfen

Deficit of CD47 Results in a Defect of Marginal Zone Dendritic Cells, Blunted Immune Response to Particulate Antigen and Impairment of Skin Dendritic Cell Migration

Journal of Immunology, 2006-05, Vol.176 (10), p.5772-5778

2006

Link zum Volltext

Verfügbarkeit prüfen

CD47 Augments Fas/CD95-mediated Apoptosis

The Journal of biological chemistry, 2005-08, Vol.280 (33), p.29637-29644

2005

Link zum Volltext

Verfügbarkeit prüfen

CD47 plays a critical role in T-cell recruitment by regulation of LFA-1 and VLA-4 integrin adhesive functions

Molecular biology of the cell, 2013-11, Vol.24 (21), p.3358-3368

2013

Link zum Volltext

Verfügbarkeit prüfen

CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model

Transplantation, 2014-08, Vol.98 (4), p.394

2014

Link zum Volltext

Verfügbarkeit prüfen

Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery

Circulation (New York, N.Y.), 1999-08, Vol.100 (8), p.849-854

1999

Link zum Volltext

Verfügbarkeit prüfen

CD47 blockade reduces ischemia/reperfusion injury and improves survival in a rat liver transplantation model

Liver transplantation, 2015-04, Vol.21 (4), p.468-477

2015

Link zum Volltext

Verfügbarkeit prüfen

Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody

Transplantation, 2016-07, Vol.100 (7), p.1480

2016

Link zum Volltext

Verfügbarkeit prüfen

The Mechanism of CD47-Dependent Killing of T Cells: Heterotrimeric Gi-Dependent Inhibition of Protein Kinase A

The Journal of immunology (1950), 2003-04, Vol.170 (7), p.3544-3553

2003

Link zum Volltext

Verfügbarkeit prüfen

Increasing Survival of Ischemic Tissue by Targeting CD47

Circulation research, 2007-03, Vol.100 (5), p.712-720

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.017

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(795)
Mit Volltextzugriff
(882)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

Phosphorylation of the BNIP3 C-Terminus Inhibits Mitochondrial Damage and Cell Death without Blocking Autophagy

Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma

Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis

CD47 Is Necessary for Inhibition of Nitric Oxide-stimulated Vascular Cell Responses by Thrombospondin-1

Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling

Differential Interactions of Thrombospondin-1, -2, and -4 with CD47 and Effects on cGMP Signaling and Ischemic Injury Responses

Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia

CD47 blockade triggers T cell-mediated destruction of immunogenic tumors

Inhibitory signaling through signal regulatory protein-α is not sufficient to explain the antitumor activities of CD47 antibodies

CD47 mediates killing of breast tumor cells via Gi-dependent inhibition of protein kinase A

Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress

CD47 Regulates Bone Mass and Tumor Metastasis to Bone

Treatment of liver ischemia–reperfusion injury by limiting thrombospondin-1/CD47 signaling

Imaging of CD47 Expression in Xenograft and Allograft Tumor Models

Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding

Deficit of CD47 Results in a Defect of Marginal Zone Dendritic Cells, Blunted Immune Response to Particulate Antigen and Impairment of Skin Dendritic Cell Migration

CD47 Augments Fas/CD95-mediated Apoptosis

CD47 plays a critical role in T-cell recruitment by regulation of LFA-1 and VLA-4 integrin adhesive functions

CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model

Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery

CD47 blockade reduces ischemia/reperfusion injury and improves survival in a rat liver transplantation model

Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody

The Mechanism of CD47-Dependent Killing of T Cells: Heterotrimeric Gi-Dependent Inhibition of Protein Kinase A

Increasing Survival of Ischemic Tissue by Targeting CD47

Suchergebnisse filtern